On June 16, 2023, the resolutions of the 2022 Annual General Meeting of Shareholders held on June 16, 2023 were announced by the issuer Guangdong Jiaying Pharmaceutical. Accordingly, the proposals put forth by Guangdong Jiaying Venture Capital to nominate Yao Yuan and Cao Junban as Non-Independent Directors, as well as Wang Yuwei as a Supervisor, were approved.